Nuwellis (NUWE) EBT Margin (2013 - 2026)
Nuwellis' (NUWE) quarterly EBT Margin came in at 245.2% in Q2 2026, up 48228.0% on a YoY basis from N/an in Q2 2025, and down 29.75% quarter-over-quarter from 188.97% in Q1 2026.
Powered by 
Analysis
Nuwellis (NUWE) EBT Margin (2013 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported EBT Margin for 14 consecutive years, with 245.2% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT Margin rose 48228.0% year-over-year to 245.2%; the trailing twelve-month figure through Jun 2026 stood at 125.9% (up 5084.0% YoY), and the FY2025 full-year result was 212.09%, down 8406.0% from the prior year.
- EBT Margin retreated to 245.2% in Q2 2026 per NUWE's latest filing, from 188.97% in the prior quarter.
- Across five years, EBT Margin topped out at 99.62% in Q3 2024 and bottomed at 727.48% in Q2 2025.
- Historically, EBT Margin has averaged 199.46% across 5 years, with a median of 191.28% in 2022.
- The sharpest annual moves came in 2025 and 2026: EBT Margin plunged 37547 bps in 2025, then jumped 48228 bps in 2026.
- Over 5 years, EBT Margin stood at 82.43% in 2022, then slumped by 163 bps to 217.13% in 2023, then soared by 70 bps to 64.47% in 2024, then tumbled by 57 bps to 100.91% in 2025, then slumped by 143 bps to 245.2% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 245.2%, 188.97%, and 100.91% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.32% |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | -245.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -245.20% |
| Mar 31, 2026 | -188.97% |
| Dec 31, 2025 | -100.91% |
| Sep 30, 2025 | 21.11% |
| Jun 30, 2025 | -727.48% |
| Mar 31, 2025 | -158.25% |
| Dec 31, 2024 | -64.47% |
| Sep 30, 2024 | 99.62% |
| Jun 30, 2024 | -352.01% |
| Mar 31, 2024 | -233.06% |
| Dec 31, 2023 | -217.13% |
| Sep 30, 2023 | -139.64% |
| Jun 30, 2023 | -233.40% |
| Mar 31, 2023 | -355.04% |
| Dec 31, 2022 | -82.43% |
| Sep 30, 2022 | -187.31% |
| Jun 30, 2022 | -193.58% |
| Mar 31, 2022 | -232.14% |
| Dec 31, 2021 | -265.83% |
| Sep 30, 2021 | -284.40% |